Riding the Ozempic wave, w/RO's CEO Zach Reitano

This podcast episode explores the unprecedented demand for weight loss drugs and the challenges and solutions faced by a company providing obesity treatments. It discusses the factors contributing to the demand for these drugs, the journey of the company in finding its hero product, the potential impact of GLP-1 drugs on the healthcare system, the importance of understanding skepticism and addressing stigma, the challenge of addressing sensitive personal issues in healthcare marketing, and the future of weight loss drugs to improve overall health and well-being.